Health & Safety Protocols

Like you, we recognize the unique and changing impact of the pandemic on our practices, families, and plans. Be confident that ASA is planning to implement appropriate health and safety protocols for attendees, exhibitors, and staff on-site at ASA® ADVANCE 2022: The Anesthesiology Business Event Event in Dallas, TX. 

The safety of meeting attendees is ASA’s top priority. As such, we continue to monitor the evolving public health guidance regarding large gathering settings and will to provide regular updates and additional guidance.

Vaccination Requirement
The most effective way to ensure the safety of all attendees is for them to be fully vaccinated against COVID-19. 

  • We encourage all attendee who attend ASA ADVANCE 2022: The Anesthesiology Business Event to be fully vaccinated
  • Only vaccines authorized by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO) will be accepted.
  • A person is considered fully vaccinated:
    • 2 weeks after their second dose in a 2-dose series, such as the Pfizer and Moderna vaccines, or
    • 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine.

Negative test results for COVID-19 from a test within three days of arrival using either molecular/PCR or antigen/"rapid" testing will also be accepted.

Process for Proof of Vaccination & Negative Test
More detailed information will be available in coming weeks on protocols.

Masks
Masks will be required for all indoor events and activities. The ASA will take into consideration guidance from the CDC and local and state health mandates at the time of ASA ADVANCE 2022: The Anesthesiology Business Event.

On-Site Health and Safety Measures
Disposable masks, alcohol wipes, and hand sanitizer will be available at registration.

Social distancing will not be required. Session rooms and the Exhibit Hall will be set up to accommodate attendees who prefer more personal space as well as those who prefer to sit closer together.

Session rooms and AV equipment will be disinfected after each session and common areas disinfected continuously. 

On-Site COVID-19 Testing
Resources near the meeting venue and hotels will be identified for attendees to obtain a rapid test for those who experience symptoms on-site and for those who must show proof of a recent negative COVID-19 test in order to board their return flight.

International Attendees
International attendees should always check current travel restrictions to the U.S. on the Centers for Disease Control and Prevention (CDC) website before planning your travel, to make sure you will be able to enter the U.S. and return to your home country.

Useful Links
U.S. Centers for Disease Control and Prevention (CDC)